Sana Biotechnology 1 article

Sana Biotechnology is a cell-therapy biotechnology company whose scientific identity centers on engineered cell medicines, with hypoimmune cell engineering defining how the therapeutic cells are selected or engineered. A further part of its cellular strategy is immune-evasive allogeneic cells, complemented by pluripotent stem cell derived therapies; pancreatic islet cell replacement supplies the disease or manufacturing context for those engineered cells. GenoMethods keeps the cell-therapy modality and individual cellular products separate; the platform identity of Sana Biotechnology also includes type 1 diabetes cell therapy.